A randomized clinical trial to compare the efficacy of three treatment regimens along with footcare in the morbidity management of filarial lymphoedema

Tropical Medicine and International Health

Volumn 10, Issue 7, 2005, Pages 698-705

  Kerketta, A S ^a   Babu, B V ^a   Rath, K ^a   Jangid, P K ^a   Nayak, A N ^a   Kar, S K ^a  

^a REGIONAL MEDICAL RESEARCH CENTRE ICMR   (India)

Author keywords

Clinical trial; Diethylcarbamazine; Footcare; India; Lymphatic filariasis; Lymphoedema; Orissa

Indexed keywords

DIETHYLCARBAMAZINE; PENICILLIN G; POVIDONE IODINE;

DISEASE TREATMENT; FILARIASIS;

ADENOLYMPHANGITIS; ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; DRUG EFFICACY; EDEMA; FILARIA; GASTROINTESTINAL DISEASE; HEALTH CARE COST; HUMAN; LYMPHANGITIS; LYMPHEDEMA; MORBIDITY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ANTI-INFECTIVE AGENTS, LOCAL; DIETHYLCARBAMAZINE; DRUG ADMINISTRATION SCHEDULE; ELEPHANTIASIS, FILARIAL; FILARICIDES; FOOT; HUMANS; LEG; LYMPHANGITIS; MIDDLE AGED; PENICILLINS; POVIDONE-IODINE; RURAL HEALTH; TREATMENT OUTCOME;

ASIA; EASTERN HEMISPHERE; EURASIA; INDIA; ORISSA; SOUTH ASIA; WORLD;

EID: 21644451765     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2005.01442.x     Document Type: Article

References (60)

1. Babu BV & Nayak AN (2003) Treatment costs and work time loss due to the episodic adenolymphangitis in lymphatic filariasis patients in rural communities of Orissa, India. Tropical Medicine and International Health 8, 1102-1109.
2. Babu BV, Acharya AS, Mallick G, Jangid PK, Nayak AN & Satyanarayana K (2001) Lymphatic filariasis in Khurda district of Orissa, India an epidemiological study. Southeast Asian Journal of Tropical Medicine and Public Health 32, 707-710.
3. Babu BV, Nayak AN, Dhal K, Acharya AS, Jangid PK & Mallick G (2002) The economic loss due to treatment costs and work loss to individuals with chronic lymphatic filariasis in rural communities of Orissa, India. Acta Tropica 82, 31-38.
4. Badger C, Seers K, Preston N & Mortimer P (2004) Antibiotics/ anti-inflamatories for reducing acute inflammatory episodes in lymphoedema of limbs. Cochrane database Syst Rev (2): CD003143.
5. Baird JB, Charles JL, Streit TG, Roberts JM, Addiss DG & Lammie PJ (2002) Reactivity to bacterial, fungal, and parasite antigens in patients with lymphedema and elephantiasis. American Journal of Tropical Medicine and Hygiene 66, 163-169.
6. Binoy C, Rao VG, Ananthakrishnan N, Kate V, Yuvraj J & Pani SP (1998) Oentoplasty in the management of filarial lymphoedema. Transaction of the Royal Society of Topical Medicine 92, 317-319.
7. Casley-Smith JR, Jamal S & Casley-Smith RJ (1993a) Reduction of filaritic lymphoedema and elephantiasis by 5, 6-benzo-alphapyrone (coumarin), and the effects of Diethylcarbamazine (DEC). Annals of Tropical Medicine and Parasitology 87, 247-258.
8. Casley-Smith JR, Wang CT & Zi-hai C (1993b) Treatment of filarial lymphoedema and elephantiasis with 5, 6-benzo-alpha-pyrone (coumarin). British Medical Journal 307, 1037-1041.
9. Colgan MP, Moore DJ & Shanik DG (1993) New approaches in the medical management of venous ulceration. Angiology 44, 138-142.
10. Cospite M (1994) Double-blind placebo-controlled evaluation of clinical activity and safety of Daflon 500 mg in the treatment of acute hemorrhoids. Angiology 45, 566-573.
11. Das PK, Srividya A, Pani SP, Ramaiah KD, Vanamail P & Dhanda V (1994) Cumulative exposure and its relationship with chronic filarial disease in bancroftian filariasis. Southeast Asian Journal of Tropical Medicine and Public Health 25, 516-521.
12. Das PK, Ramaiah KD, Vanamail P et al. (2001) Placebo-controlled community trial of four cycles of single dose diethylcarbamazine or iverrnectin against Wuchereria bancrofti infection and transmission in India. Transactions of the Royal Society of Tropical Medicine and Hygiene 95, 336-341.
13. Das LK, Reddy GS & Pani SP (2003) Some observations on the effect of Daflon (micronized purified flavonoid fraction of Rutaceae aurantiae) in bancroftian filarial lymphoedema. Filaria Journal 2, 5.
14. Dash AP, Mohapatra N, Hazra RK & Acharya AS (1998) Transmission dynamics of filariasis in Khurda district of Orissa, India. South East Asian Journal of Tropical Medicine and Public Health 29, 137-140.
15. Dreyer G, Medeiros Z, Netto MJ, Leal NC, de Castro LG & Piessens WF (1999) Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 413-417.
16. Dreyer G, Noroes J, Figueredo-Silva J & Piessens WF (2000) Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitology Today 16, 544-548.
17. Ewert A, Reitmeyer JC & Folse D (1980) Chronic infection of cats with Brugia malayi and Streptococcus. South East Asian Journal of Tropical Medicine and Public Health 11, 32-39.
18. Foldi E, Foldi M & Clodius L (1989) The lymphoedema chaos: a lancet. Annals of Plastic Surgery 22, 505-515.
19. Freedman DD, Thuy B, Paulo DAF et al. (1995) Lymphoscmtigraphic assessment of the effect of Diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis. American Journal of Tropical Medicine and Hygiene 52, 258-261.
20. Guilhou JJ, Debure O, Marzin L et al. (1997) Efficacy of Daflon 500 mg in venous leg ulcer healing: a double-blind, randomized, controlled versus placebo trial in 107 patients. Angiology 48, 77-85.
21. Gyapong JO, Gyapong M, Evans DB, Aikins MK & Adjei S (1996) The economic burden of lymphatic filariasis in Northern Ghana. Annals of Tropical Medicine and Parasitology 19, 39-48.
22. ICMR (2000) Statement of General Principles on Ethical Considerations Involving Human Subjects. Ethical Guideline of Biomedical Research in Human Subjects 1-8. Indian Council of Medical Research, New Delhi.
23. Kar SK, Kar PK & Mania J (1992) Tissue tonometry: a useful tool for assessing filarial lymphedema. Lymphology 25, 55-61.
24. Le Deyehat C, Khodabandehlou T, Vimeux M & Kempf C (1997) Evaluation of haemorrhagical and microcirculatory disturbances in chronic venous insufficiency: activity of Daflon 500 mg. International Journal of Microcirculation Clinical and Experimental 17, 27-33.
25. Manjula Y, Kate V & Ananthkrishnan N (2002) Evaluation of sequential intermittent pneumatic compression in filarial lymphoedema. The National Medical Journal of India 15, 192-194.
26. Meyer OC (1994) Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease. Angiology 45, 579-584.
27. Michael E, Bundy DAP & Grenfell BT (1996) Reassessing the global prevalence and distribution of lymphatic filariasis. Parasitology Today 112, 409-428.
28. Montestruc E, Courmes E &c Fontan R (1960) Endemic lymphangitis in French Guiana and its relation to W. bancrofti filariasis. Indian Journal of Malariology 14, 637-650.
29. Olszewski WL (1996) Episodic dermatolymphangitis (DLA) in patients with lymphoedema from lower extremities before and after administration of benzithine pencillin: a preliminary study. Lymphology 29, 126-131.
30. Olszewski WL, Jamal S, Manokaran G et al. (1992) Skin changes in filarial lymphoedema. Progress of Lymphology 13, 193-195.
31. Olszewski WL, Jamal S, Lukomsa B, Kubika U & Manokaran G (1993) Skin changes in filarial and non filarial lymphoedema of lower extremities. Tropical Medicine and Parasitology 44, 40-44.
32. Olszewski WL, Jamal S, Manokaran G et al. (1999) Bacteriological studies of blood, tissue fluid, lymph and lymph nodes in patients with acute dermatolymphangioadenitis (DLA) in course of filarial lymphoedema. Acta Tropica 73, 217-224.
33. Ottesen EA (2000) The global programme to eliminate lymphatic filariasis. Tropical Medicine and International Health 5, 591-594.
34. Ottesen EA, Duke BOL, Karam M & Behbehani K (1997) Strategies and tools for the control/elimination of lymphatic filariasis. Bulletin of World Health Organization 75, 491-503.
35. Pani SP, Knshnamoorthy K, Prathiba J & Rao AS (1989) Diethylcarbamazine and supportive measures for the treatment of brugian filariasis. The National Medical Journal of India 2, 260-263.
36. Pani SP, Krishnamoorthy K, Rao AS & Prathiba J (1990) Clinical manifestation in malayan filariasis with special reference to lymphoedema grading. Indian Journal of Medical Research 81, 200-207.
37. Pani SP, Yuvaraj J, Vanamali P et al. (1995) Episodic adenolymphangitis and lymphoedema in patients with bancroftian filariasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 89, 211-214.
38. Partono F (1987) The spectrum of disease in lymphatic filariasis. In: Filariasis. Ciba Foundation Symposium No. 127. pp. 15-31.
39. Pecking AP (1995) Evaluation by lymphoscintigraphy of the effect of a micronized flavonoid fraction (Daflon 500 mg) in the treatment of upper limb lymphedema. International Angiology 14 (Suppl. 1), 39-43.
40. Pecking AP, Fevier B, Wargon C & Pillion G (1997) Efficacy of Daflon 500 mg in the treatment of lymphedema (secondary to conventional therapy of breast cancer). Angiology 48, 93-98.
41. Ramaiah KD, Vijay Kumar KN, Ramu K, Pani SP & Das PK (1997) Functional impairment caused by lymphatic filariasis in rural areas of south India. Tropical Medicine and International Health 2, 832-838.
42. Ramaiah KD, Ramu K, Guyaatt H, Vijay Kumar KN & Pani SP (1998) Direct and indirect costs of acute form of lymphatic filariasis in rural areas in Tamilnadu, South India. Tropical Medicine and International Health 2, 832-838.
43. Ramaiah KD, Guyatc H, Ramu K, Vanamail PP, Pani SP & Das PK (1999) Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in South India. Tropical Medicine and International Health 4, 19-25.
44. Rao VG, Ananthakrishnan N, Pani SP, Kate V, Yuvraj J & Krishnamoorthy K (1999) Factors influencing response to lymphono-venous shunt in filarial lymphoedema. The National Medical Journal of India 12, 55-58.
45. Shenoy RK, Sandhya K, Suma TK & Kumaraswami V (1995) A preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities. South East Asian Journal of Tropical Medicine and Public Health 26, 301-305.
46. Shenoy RK, Suma TK, Rajan K & Kumaraswami V (1998) Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb. Annals of Tropical Medicine and Parasitology 92, 587-594.
47. Shenoy RK, Kumarswami V, Suma TK, Rajan K & Radhakuttyamma G (1999) A double blind placebo controlled study of the efficacy of oral pencillin diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphodema caused by brugian filariasis. Annals of Tropical Medicine and Parasitology 93, 367-377.
48. Struckmann JR (1999) Clinical efficacy of micronized flavonoid fraction: an overview. Journal of Vascular Research 36 (Suppl. 1), 37-41.
49. Suma TK, Shenoy RK, Varghese J, Kuttikkal W & Kumarswami V (1997) Estimation of ASO titer as an indicator of streptococcal infection precipitating acute adenolymphangitis in brugian lymphatic filaria. Southeast Asian Journal of Tropical Medicine and Public Health 28, 826-830.
50. Suma TK, Shenoy RK & Kumaraswami V (2002) Efficacy and sustainability of a footcare programme in preventing acute attacks of adenolymphangitis in brugian filariasis. Tropical Medicine and International Health 7, 763-766.
51. Vaqas B & Ryan TJ (2003) Lymphoedema: pathophysiology and management in resource-poor settings - relevance for lymphatic filariasis control programme. Filaria Journal 2, 4.
52. Vincent AL, Rojas CAU, Ayoub EM, Ottesen EA & Harden EG (1998) Filariasis and crisipela in Santo Domingo. Journal of Parasitology 84, 557-561.
53. Webster EH (1943) Filariasis among white immigrants in Samoa. US Naval Medical Bulletin 46, 186-192.
54. WHO (1984) Fourth Report of the WHO Expert Committee on Filariasis, WHO Technical Report Series 702. World Health Organization, Geneva.
55. WHO (1985) Lymphatic Pathology and Immunopathology in Filariasis. Report of the Twelfth Meeting in Filariasis. TDR/FIL-SWG12, 85.3. World Health Organisation, Geneva.
56. WHO (1992) Lymphatic Filariasis: Disease and its Control. Fifth Report of the WHO Expert Committee on Filariasis. Technical Report Series No. 821. World Health Organization, Geneva.
57. WHO (1995) Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products. WHO Technical Report Series No. 850 Annex 3, 31-33. World Health Organisation, Geneva.
58. WHO (1996) Coumarin (Lodema). WHO Pharmaceutical Newsletter 10, 2.
59. World Medical Association (1995) Declaration of Helsinki-Recommendations Guiding Physicians in Biomedical Research Involving Human Subjects. WHO Technical Report Series 850 Annex 3, 30-33. World Health Organisation, Geneva.
60. Zelikovski A, Deutsch A & Reiss R (1993) The sequential pneumatic compression device in surgery for lymphedema in the limbs. Journal of Cardiovascular Surgery (Tarino) 24, 122-126.